 Proceedings
 Open Access
 Published:
Application of noncollapsing methods to the genebased association test: a comparison study using Genetic Analysis Workshop 18 data
BMC Proceedingsvolume 8, Article number: S53 (2014)
Abstract
Rare variants have been proposed to play a significant role in the onset and development of common diseases. However, traditional analysis methods have difficulties in detecting association signals for rare causal variants because of a lack of statistical power. We propose a twostage, genebased method for association mapping of rare variants by applying four different noncollapsing algorithms. Using the Genome Analysis Workshop18 whole genome sequencing data set of simulated blood pressure phenotypes, we studied and contrasted the falsepositive rate of each algorithm using receiver operating characteristic curves. The statistical power of these methods was also evaluated and compared through the analysis of 200 simulated replications in a smaller genotype data set. We showed that the Fisher's method was superior to the other 3 noncollapsing methods, but was no better than the standard method implemented with famSKAT. Further investigation is needed to explore the potential statistical properties of these approaches.
Background
During the past five years, genomewide association studies (GWAS) have rapidly become a standard method for discovering susceptible genes for a variety of complex diseases [1]. Up to now, hundreds of loci with more than 3000 singlenucleotide polymorphisms from approximately 7000 GWAS have been reported to be associated with complex diseases [2]. Nevertheless, a large proportion of heritability is left unexplainable from GWAS results that are mainly based on association signals captured by common variants [3]. One potential explanation for this "missing heritability enigma" has been the contribution of rare variants, which is often not assessed in regular GWAS studies [3]. Unfortunately, traditional methods often fail in association mapping of rare variants because of poor statistical power. Several methods have been proposed to detect association signals for rare variants with improvements in statistical power compared to traditional methods [4–6].
As part of Genetic Analysis Workshop 18 (GAW18), simulated phenotypic data, based on a real sequencing data set, were provided to the scientific community to evaluate and compare statistical genetic methods for rare variants association mapping. We consider a twostage, genebased method to detect association signals for both common and rare variants. We first obtain significance p values by fitting a mixed effects model for each variant, and then apply 4 noncollapsing algorithms to obtain the genewise association p values. Collapsing (or burden) methods combine variant information by assuming consistent direction of effects across variants. None of the methods considered here adopt this assumption, although some (Fisher's, Gene Set Enrichment Analysis [GSEA], sequence kernel association test [SKAT]) do combine variant information.
Methods
Model fitting and algorithms
A mixed linear model was fitted for each variant as described in previous literature [7]. The model was defined as:
$Y=X\beta +Qv+Z\mu +\u03f5$
where Y is the quantitative trait of interest (we used firstvisit systolic blood pressure [SBP] data were used in this study); × is the genotype; β is the fixed effects of the genotypes; and Q represents the population structure variables. In this study, we chose the first 10 principal components from principal component analysis (PCA) for Q;ν is the fixed effects of Q;Z is the variable that evaluates familial relatedness (the theoretical kinship matrix was used for Z); and µ is the random effects coefficient for Z that corrects the polygenic impact.
After obtaining the variantwise p values by fitting the mixed linear model, four noncollapsing algorithms were modified and applied to the data set to obtain the genewise association p values. The algorithms of the 4 methods are summarized as followed:

1.
Naïve method. The most significant variantwise p values within a specific gene were chosen as the genewise association p values.

2.
Fisher's method [8]. The genewise statistics were calculated through the following equation:
$$X=2{\displaystyle \sum _{i=1}^{k}}{\mathsf{\text{log}}}_{e}\left({p}_{i}\right)$$
where p_{ i } is the p value for variant i, and k is the total number of variants within a specific gene. Because many variants are highly correlated, the basic assumption of independent tests for Fisher's method is violated. Fisher's formula will not have a chisquare distribution, so we assessed the significance via permutation analysis.

3.
Simes' method [9]. The genewise p value was summarized by the following equation:
$${P}_{simes}=\underset{i}{\mathrm{min}}\left\{\frac{k{p}_{i}}{i}\right\}$$
where p_{ i } is the p value for variant i, and k is the total number of variants within a specific gene.

4.
GSEA method [10, 11]. The test statistics (indicated as ES score) were aggregated from variantwise p values within each gene via a KolmogorovSmirnovlike process in which running sums are accumulated. The equation is given as:
$$ES\left(S\right)=\underset{1\le j\le N}{\mathsf{\text{max}}}\left\{{\displaystyle \sum _{{G}_{j*\u03f5S},j*\le j}}\frac{{r}_{\left(j*\right)}{}^{p}}{{N}_{R}}{\displaystyle \sum _{{G}_{j*\notin S},j*\le j}}\frac{1}{N{N}_{H}}\right\}$$
where N is the total number of variants, r(j) is the j^{th} largest statistic values, N_{ H } is the variant number of a given gene, S is any given gene, P is the parameter that gives a higher weight to variants with extreme statistic value, arbitrarily set to 1 in this study, and N_{ R } is given by:
Statistical significance and adjustment for multiple hypothesis testing were assessed by a 1000permutationbased procedure. A familywise error rate (FWER) procedure was used to adjust for multiple hypothesis testing. The FWER is a highly conservative correction procedure that seeks to ensure that the list of reported results does not include even a single falsepositive gene. In this study, the FWER p value was calculated as the fraction of all permutations whose highest statistics (or smallest p values) in all genes is higher than a given gene. In addition to the 4 noncollapsing algorithms introduced above, we also included 2 standard rare variants analysis methods: SKAT [12] and famSKAT [13] in our analysis. FamSKAT is an extended version of SKAT and can analyze rare variant when family correlations are present. Furthermore, to evaluate the statistical power of these methods, we extracted the variant information related to the 22 truepositive genes located on chromosome 3 and analyzed these data for all 200 simulated phenotype replicates.
Data and computation
The chromosome 3 sequencing data were analyzed only for phenotype replicate number 1 because of a huge computational burden. The sequencing data were annotated by ANNOVAR[14]. Intergenic variants (variants at least 1 kilobase [kb] away from any known gene regions) were excluded. We kept only variants mapped to regulatory regions.
To preserve the familial structure, a permutationofresiduals procedure was applied for the 1000 permutations [15, 16]. First, we fitted a mixed effects linear model on the phenotypic data with all predictors in the model (except for genotype term) and preserve the residuals for these models. Second, we shuffled the residuals (rather than the phenotypic data used in an ordinary permutation procedure) and randomly assigned them to each subject and generated 1000 phenotypic data replicates. And third, we obtained the permuted statistics and p values by fitting a univariate linear model with genotype as the only predictor of the residuals. This method may introduce potential bias to the permuted statistics and p values comparing to directly fitting the full model. To quantify this potential bias, we randomly chose 1429 variants and calculated the percentage difference of the −log10 scaled p values obtained from directly fitting a full model and from the 2step permutation procedure proposed in this paper.
Genotypes were coded as dominant, that is, the genotypes with 1 or 2 minor alleles were coded as 1, while genotypes with 2 major alleles were assigned 0. Variants with minor allele frequency >0.3 in genomewide association data set were selected for PCA. We used Eigenstrat 3.0 for this analysis [17]. The R package kinship2 (http://cran.rproject.org/web/packages/kinship2/index.html) was used to calculate the kinship coefficient matrix for our data set. The R package coxme (http://cran.rproject.org/web/packages/coxme/index.html) was implemented for fitting the mixed linear model. The R package SKAT (http://cran.rproject.org/web/packages/SKAT/index.html) was implemented for rare variant analysis with SKAT. The R source code for famSKAT was downloaded (http://www.bumc.bu.edu/linga/research/publications/famskat/) and implemented for rare variant analysis. Receiver operating characteristic (ROC) curves were made and compared among the 4 algorithms and two standard methods.
Results
The data consisted of 1237 genes with 87,190 variants that passed the annotation criteria were extracted from the sequencing data set of chromosome 3 for 849 subjects. After fitting the mixed linear model, the QQ plot and histogram of p values of these 87,190 variants is shown in Figure 1. To compare the 4 noncollapsing methods and the 2 standard methods, ROC curves based on these 6 methods were calculated and are shown in Figure 2.
Data for the 22 truepositive genes with 1098 variants were extracted and used for analysis with 200 simulated phenotype replicates. The statistical power information for the 6 methods was summarized and is presented in Table 1. The results of the permutation bias analysis showed that the percentage difference was only approximately 10%, and the correlation coefficient of variantwise statistics was 0.9959. These results indicate that the effects of this bias will be limited.
Discussion
The noncollapsing methods introduced in this paper have been broadly used in testing the significance of biological pathways in GWAS data sets [11]. When we substitute the term"pathway" in these noncollapsing algorithms for the term "gene" in sequencing analysis and "gene" for "variants," we can apply these noncollapsing algorithms to genebased association detection through modifications. An obvious advantage of aggregating p values (or statistics) by applying noncollapsing algorithms, compared to ordinary variants collapsing methods, is that it is a method free of the assumption that all the causal variants from a gene have effects in the same direction. This assumption may not be held in many scenarios even though it is the assumed in many existing rare variants association mapping procedures.
Another advantage of this research is the utilization of residualsofpermutation procedure [15, 16]. Conducting a permutation on family data has been a challenge in statistical genetics research. Ordinary permutation procedures have been mostly utilized in casecontrol data, which simply shuffle the phenotypic data and randomly assigns them to each subject, thus cannot be directly applied to family data because it destroys the family structure. In this paper, instead of shuffling the phenotypic data, we shuffled the residuals obtained from fitting a linear mixed effects model without genotype. These residuals have already accounted familial relatedness in the model fitting step and therefore our permutation procedure preserves the familial structure.
From the ROC curves in Figure 2 we note that, overall, the Simes' method performed a little better than the other 5 methods, and that GSEA, SKAT, and famSKAT did not perform as well. The other 2 methods were slightly better than the GSEA, SKAT, and famSKAT methods. However, when we limit the falsepositive rate to be smaller than 0.1, as shown in the right hand plot of Figure 2 (in practice, only a high truepositive rate with a low falsepositive rate is of interest), we see that Fisher's method and famSKAT performed better than the other methods at the low falsepositive rate range. They both capture approximately 15% of the causal genes (true positives) at a cost of only 5% falsepositive signals. However, we did not test the significance of the ROC curves, so that all these observed differences could just be noise.
From the power analysis results in Table 1, we see that the gene MAP4 was successfully identified to be significant for all simulated 200 replicates. All six methods achieved 100% power for this gene. This result is reasonable because, according to the "answer sheet", MAP4 has the most "causal variants" and these variants have a relatively larger effect size comparing to the variants within other genes. However, this result was obtained when we only analyzed 22 genes. For a genomescale analysis, the significant signals may be missed as a consequence of correction for multiple comparisons. We have analyzed the whole genotypic data set of chromosome 3 with simulated phenotypic replicate number 1 (1237 genes and 87,190 variants). The result indicated that only naïve method and the 2 standard methods identified gene MAP4 to be significant. For the other 21 genes, the largest power was 0.275, which was achieved by SKAT for LOC152217.
Several previous researchers have already applied the noncollapsing methods proposed in this paper to conduct genebased analysis [18, 19]. However, this previous work has mainly focused on common variants in GWAS data set. As an attempt to apply these noncollapsing algorithms to genebased association tests using sequencing data, we have demonstrated some potentially promising aspects of this approach. However, several problems remain unaddressed. One important issue is the computational intensity. In this study, we have utilized a multiprocessor computing server with a 23 × 2.8 GHz CPU and 64GB of memory. The most timeconsuming part of our analysis is the permutationofresiduals process and linear model fitting of the permuted data sets. We have paralleled this process into 20 jobs, but it still takes around 30 hours to complete (this is only the work done for 1 chromosome).
Compared to the permutation process, the p value combination step can be completed much faster (~30 minutes). Because a lot of the non collapsing algorithms require permutation procedures to create null distribution of the statistics, it is somewhat difficult to implement them on a genomewidescale data set. In addition, many noncollapsing algorithms cannot be utilized for a genebased association test directly without proper modifications. The choice of parameters in noncollapsing algorithm for rare variant association detection is more an art than a science. Finally, adjustment for multiple hypothesis testing is another important issue that needs to be addressed.
Our results indicate that the FWER method is too conservative. For the future work, hierarchical modeling combined with the Markov chain Monte Carlo method may provide better solution to the multiple hypothesis testing problems [20].
Conclusions
Our findings suggest that all the four new methods we proposed along with the standard method implemented with famSKAT were poor in statistical power. In sum, more research is still needed in the statistical method of association mapping for rare variants in the future.
References
 1.
Visscher PM, Brown MA, McCarthy MI, Yang J: Five years of GWAS discovery. Am J Hum Genet. 2012, 90: 724. 10.1016/j.ajhg.2011.11.029.
 2.
A Catalog of Published GenomeWide Association Studies. [http://www.genome.gov/gwastudies]
 3.
Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, et al: Finding the missing heritability of complex diseases. Nature. 2012, 461: 747753. 10.1038/nature08494.
 4.
Li B, Leal SM: Methods for detecting associations with rare variants for common diseases: application to analysis of sequence data. Am J Hum Genet. 2008, 83 (3): 311321. 10.1016/j.ajhg.2008.06.024.
 5.
Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X: Rarevariant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet. 2011, 89: 8293. 10.1016/j.ajhg.2011.05.029.
 6.
Neale BM, Rivas MA, Voight BF, Altshuler D, Devlin B, OrhoMelander M, Kathiresan S, Purcell SM, Roeder K, Daly MJ: Testing for an unusual distribution of rare variants. PLoS Genet. 2011, 7: e100132210.1371/journal.pgen.1001322.
 7.
Zhang QY, Chung DY, Kraja A, Borecki II, Province MA: Methods for adjusting population structure and familial relatedness in association test for collective effect of multiple rare variants on quantitative traits. BMC Proc. 2011, 5 (Suppl 9): S3510.1186/175365615S9S35.
 8.
Wikipedia. [http://en.wikipedia.org/wiki/Fisher's_method]
 9.
Simes RJ: An improved Bonferroni procedure for multiple tests of significance. Biometrika. 1986, 73: 751754. 10.1093/biomet/73.3.751.
 10.
Wang K, Li MY, Bucan M: Pathwaybased approaches for analysis of genomewide association studies. Am J Hum Genet. 2007, 81: 12781283. 10.1086/522374.
 11.
Zhang TX, Ruczinski I, Beaty TH: Candidate pathway based analysis for cleft lip with or without cleft palate. Stat Appl Genet Mol Biol. 2012, 11: 210.2202/15446115.1717.
 12.
Wu MC, Lee S, Cai T, Li Y, Boehnke M, Lin X: Rarevariant association testing for sequencing data with the sequence kernel association test. Am J Hum Genet. 2011, 89: 8293. 10.1016/j.ajhg.2011.05.029.
 13.
Chen H, Meigs JB, Dupuis J: Sequence kernel association test for quantitative traits in family samples. Genet Epidemiol. 2013, 37: 196204. 10.1002/gepi.21703.
 14.
Wang K, Li M, Hakonarson H: ANNOVAR: Functional annotation of genetic variants from nextgeneration sequencing data. Nucleic Acids Res. 2010, 38: e16410.1093/nar/gkq603.
 15.
Anderson MJ, Robinson J: Permutation tests for linear models. Aust N Z J Stat. 2001, 43: 7588. 10.1111/1467842X.00156.
 16.
Anderson MJ: Permutation tests for univariate or multivariate analysis of variance and regression. Can J Fish AquatSci. 2001, 58: 626639. 10.1139/f01004.
 17.
Patterson N, Price AL, Reich D: Population structure and eigenanalysis. PLoS Genet. 2006, 2: e19010.1371/journal.pgen.0020190.
 18.
Lehne B, Lewis CM, Schlitt T: From SNPs to genes disease association at the gene level. PLoS One. 2011, 6: e2013310.1371/journal.pone.0020133.
 19.
Huang H, Chanda P, Alonso A, Bader JS, Arking DE: Genebased tests of association. PLoS Genet. 2011, 7: e100217710.1371/journal.pgen.1002177.
 20.
Kim LL, Fijal BA, Witte JS: Hierarchical modeling of the relation between sequence variants and a quantitative trait: addressing multiple comparison and population stratification issues. Genet Epidemiol. 2001, 21 (suppl 1): S668S673.
Acknowledgements
The authors thank Peter Jones for technical support and advice. This work is supported in part by U.S. Public Health Service (USPHS) grant U24MH68457.
The GAW18 whole genome sequence data were provided by the T2DGENES Consortium, which is supported by NIH grants U01 DK085524, U01 DK085584, U01 DK085501, U01 DK085526, and U01 DK085545. The other genetic and phenotypic data for GAW18 were provided by the San Antonio Family Heart Study and San Antonio Family Diabetes/Gallbladder Study, which are supported by NIH grants P01 HL045222, R01 DK047482, and R01 DK053889. The Genetic Analysis Workshop is supported by NIH grant R01 GM031575.
This article has been published as part of BMC Proceedings Volume 8 Supplement 1, 2014: Genetic Analysis Workshop 18. The full contents of the supplement are available online at http://www.biomedcentral.com/bmcproc/supplements/8/S1. Publication charges for this supplement were funded by the Texas Biomedical Research Institute.
Author information
Additional information
Competing interests
The authors declare that they have no competing interests.
Authors' contributions
TXZ and JPR designed the overall study. TXZ and YRX conducted statistical analyses. TXZ and YRX drafted the manuscript. All authors read and approved the final manuscript. TXZ and JPR revised the manuscript critically.
Rights and permissions
About this article
Published
DOI
Keywords
 Receiver Operating Characteristic Curve
 Rare Variant
 Association Mapping
 Multiple Hypothesis Testing
 Genetic Analysis Workshop